Mankind Pharma Ltd
NSE:MANKIND
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
IN |
|
China Pacific Insurance Group Co Ltd
SSE:601601
|
CN |
|
Denso Corp
TSE:6902
|
JP |
|
V
|
Volkswagen AG
PSE:VOW
|
DE |
Wall St Price Targets
MANKIND Price Targets Summary
Mankind Pharma Ltd
According to Wall Street analysts, the average 1-year price target for MANKIND is 2 907 INR with a low forecast of 2 077.57 INR and a high forecast of 3 381 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MANKIND's stock price target?
Price Target
2 907
INR
According to Wall Street analysts, the average 1-year price target for MANKIND is 2 907 INR with a low forecast of 2 077.57 INR and a high forecast of 3 381 INR.
What is the Revenue forecast for Mankind Pharma Ltd?
Projected CAGR
13%
Over the last 5 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 13%.
What is the Gross Profit forecast for Mankind Pharma Ltd?
Projected CAGR
14%
Over the last 5 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 14%.
What is the Operating Income forecast for Mankind Pharma Ltd?
Projected CAGR
17%
Over the last 5 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 17%.
What is the Pre-Tax Income forecast for Mankind Pharma Ltd?
Projected CAGR
27%
Over the last 5 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 27%.
What is the Net Income forecast for Mankind Pharma Ltd?
Projected CAGR
23%
Over the last 5 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 3 years is 23%.